Earnings History Data for Citius Pharmaceuticals, Inc. (CTXR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in the development and commercialization of critical care products targeting medical needs with a focus on anti-infective products, adjunctive cancer care and prescription products. Citius Pharmaceuticals, Inc. is headquartered in Cranford, New Jersey.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-08-2024 | PM | CTXR | Citius Pharmaceuticals, Inc. | 160.80 | -0.06 | -0.05 | -0.06 | Citius Pharmaceuticals GAAP EPS of -$0.06 misses by $0.01 [8/13/2024 2:14 AM] |
0.6052 | -0.09 (-12.44%) |
0.66 | -0.03 (-4.51%) |
0.48 - 1.07 | 3,738,963 | 3,040,000 | 241,602 | ||
| 14-05-2024 | AH | CTXR | Citius Pharmaceuticals | 111.00 | -0.05 | -0.06 | 0.00 | Citius Pharmaceuticals Non-GAAP EPS of -$0.05 [5/14/2024 5:03 PM] |
0.6190 | -0.07 (-9.98%) |
0.67 | -0.02 (-2.37%) |
0.60 - 1.42 | 2,320,123 | 1,180,000 | 3,835 | ||
| 14-02-2024 | AH | CTXR | Citius Pharmaceuticals | 114.00 | -0.06 | 0.13 | 0.00 | Citius Pharmaceuticals GAAP EPS of -$0.06 [2/14/2024 4:38 PM] |
0.8330 | 0.06 (7.92%) |
0.78 | 0.01 (1.04%) |
0.60 - 1.71 | 915,044 | 700,000 | 13,762 | ||
| 14-08-2023 | AH | CTXR | Citius Pharmaceuticals | 158.00 | -0.06 | -0.06 | 0.00 | Citius Pharmaceuticals GAAP EPS of -$0.06 beats by $0.01 [8/14/2023 5:11 PM] |
0.8645 | -0.06 (-6.33%) |
0.95 | 0.03 (2.94%) |
0.77 - 1.71 | 1,402,141 | 1,330,000 | 6,148 | ||
| 12-08-2021 | AH | CTXR | Citius Pharmaceuticals, Inc. | 252.00 | -0.05 | -0.05 | 0.00 | Citius Pharmaceuticals reports Q3 results [8/12/2021 5:03 PM] |
1.80 | -0.04 (-2.43%) |
1.82 | -0.03 (-1.62%) |
0.78 - 4.56 | 1,672,804 | 2,590,000 | 14,800 | ||
| 13-05-2021 | PM | CTXR | Citius Pharmaceuticals, Inc. | 303.08 | -0.04 | -0.08 | -0.13 | Citius Pharmaceuticals EPS beats by $0.05 [5/13/2021 7:44 AM] |
1.90 | -0.19 (-9.09%) |
2.10 | 0.01 (0.48%) |
0.77 - 2.90 | 8,557,501 | 8,870,000 | 305,893 | ||